The largest database of trusted experimental protocols

245 protocols using il 21

1

Assessing IL-21 Regulation of B Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenic CD19+ B cells from BALB/c mice were purified using magnetic mouse CD19 MicroBeads (Miltenyi Biotec) and cultured in flat-bottom 96-well plates (Corning). To assess effects of IL-21 on the expression of c-Myc, BATF, IRF4, p-S6, cyclin D3, and Foxo1, cells were incubated with the indicated concentration of IL-21 (PeproTech) and 20 μg/ml of anti-mouse CD40 (FGK4.5) for 24 h at 37°C. To inhibit Foxo1, cells were treated with AS1842856 (2 μM; MedChem Express) for 1 h, followed by further incubation with 20 μg/ml of anti-CD40 mAb with or without 80 ng/ml of IL-21 for 16 h. To study Foxo1 intracellular localization, cells were rested for 30 min at 37°C, and where indicated, further incubated with 10 μg/ml of goat anti-mouse IgM (μ chain specific; Thermo Fisher Scientific) for 10 min followed by a 30-min stimulation with 80 ng/ml of IL-21.
+ Open protocol
+ Expand
2

Isolation and Culture of B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Magnetic separation (Miltenyi Biotec) was used to purify CD19+ B cells from BALB/c or p110δD910A spleen. Cells (1 × 106) were cultured for 16 h alone or in the presence of 200 ng/ml IL-21 (PeproTech) or 10 ng/ml IL-4 (PeproTech). For STAT3 inhibition experiments cultures were supplemented with 10, 50, or 100 μM S3I-201 (Calbiochem) as indicated. For PI3K inhibition experiments cultures were supplemented with 10 μM LY-294002 (Invitrogen) as indicated. For assessment of activated STAT proteins cells were cultured for 2 h alone or in the presence of 200 ng/ml IL-21 (PeproTech). For experiments to determine the target of IL-21, 2.5 × 104 BALB/c or IL-21R−/− B cells were cultured with 2.5 × 104 magnetically separated (Miltenyi Biotec) CD4+CD25 T cells from BALB/c or IL-21R−/− lymph node for 16 h alone or in the presence of 200 ng/ml IL-21 (PeproTech).
+ Open protocol
+ Expand
3

Feeder-Supported In Vitro GC B Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
NIH-3T3 feeder cells that stably express CD40L and BAFF were seeded into 96-well plates at 15,000 cells per well in 100 μL complete RPMI-1640 one day before receiving B cells. On day 0, single FAS+GL7+ GC B cell was sorted directly into these feeder wells, supplemented with recombinant mouse IL-4 (2 ng/mL, Peprotech) and IL-21 (2.5 ng/mL, Peprotech). On day 2, 50 μL culture medium was removed and each well was replenished with 100 μL fresh culture medium containing IL-21 (2.5 ng/mL, Peprotech). From day 3 to 8, 100 μL old medium was replaced with 100 μL fresh medium containing IL-21 (2.5 ng/mL, Peprotech) for each well every day. On day 9 and 10, culture supernatants were harvested (antibody-secreting cell supernatants) and used as cytometry staining or ELISA detection reagent for subsequent assays. These supernatants typically contained ~10 μg/mL total mouse IgG by ELISA. Single-cell cultures in plates were frozen stored at –80 °C until subsequent use for cloning of Ig-coding sequences using a published protocol.58 (link)
+ Open protocol
+ Expand
4

Culturing Cells with IL-21 and CD40L

Check if the same lab product or an alternative is used in the 5 most similar protocols
IL-21: As described in our earlier publication, IL-21 (100 ng/ml, PeproTech EC, UK) was added to cultures containing 0.16×106 cells/ml.[31] (link) The cultures were readjusted on third day to 0.16×106 cells/ml and IL-21 was re-added. The cells were harvested on the 6th day for analysis.
CD40 ligand, CD40L: 0.5×106 irradiated (15,000RAD) L or CD40L-L cells were plated in wells of a 24 well plate and used 24 hours later. Equal number of MEC1 and MEC2 cells were seeded on the monolayer and incubated for 3 days at 37°C and 5% CO2[33] (link).
+ Open protocol
+ Expand
5

Magnetic Separation of B Cells for IL-21 Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Magnetic separation (Miltenyi Biotec) was used to purify CD19+ B cells from BALB/c or p110δD910A spleen. 1×106 cells were cultured for 16 hours alone or in the presence of 200ng/ml IL-21 (Peprotech) or 10ng/ml IL-4 (Peprotech). For STAT3 inhibition experiments cultures were supplemented with 10, 50 or 100μM S3I-201 (Calbiochem) as indicated. For PI3K inhibition experiments cultures were supplemented with 10μM LY-294002 (Invitrogen) as indicated. For assessment of activated STAT proteins cells were cultured for 2 hours alone or in the presence of 200ng/ml IL-21 (Peprotech). For experiments to determine the target of IL-21 2.5×104 BALB/c or IL-21R−/− B cells were cultured with 2.5×104 magnetically separated (Miltenyi Biotec) CD4+CD25− T cells from BALB/c or IL-21R−/− lymph node for 16 hours alone or in the presence of 200ng/ml IL-21 (Peprotech).
+ Open protocol
+ Expand
6

Cytokine Stimulation of Splenocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleens were aseptically removed from naïve WT, Il21r-/-, STAT3flox/flox or CD4stat3-/- mice and cells were mechanically disrupted through a 100 μm cell strainer (BD Biosciences, San Jose, CA) using the plunger of a 6 ml syringe. RBCs were lysed in ACK lysing buffer (Lonza, Walkersville, MD), and the remaining cells were washed twice with ice-cold PBS. A total of 5×106 splenocytes were cultured in duplicate in 1 ml of RPMI 1640 (Gibco) supplemented with 10% FBS and 100 μg/ml penicillin/streptomycin (all from Gibco). Cells were allowed to rest for 2 additional hours at 37°C and subsequently were stimulated in the presence of recombinant murine IFN-γ, IL-17A, IL-21 and IL-22 (20 ng/ml; Peprotech, Rocky Hill, New Jersey, USA) alone or in combination (IFN-γ+IL-17A; IFN-γ+IL-21; IFN-γ+IL-22; 20 ng/ml each). Cells receiving no cytokine treatments were used as controls. Cells were harvested at different intervals following the addition of cytokines and were stained with indicated antibodies.
+ Open protocol
+ Expand
7

Investigating CD4+ T Cell Response in IL-21R-/- Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD19+ B cells from BALB/c or IL-21R−/− spleen were isolated by magnetic separation (Miltenyi Biotec) and cultured for 16 h with 1 μg/ml OVA peptide. Peptide-pulsed cells (3 × 106) were injected i.v. into IL-21R−/− recipients. magnetic separation (Miltenyi Biotec) was used to purify CD4+ cells from IL-21R−/− DO11.10 TCR+ lymph node. Twenty-four hours after B cell transfer, a total of 2 × 106 CellTrace Violet–labeled IL-21R−/− DO11.10 TCR+ T cells were injected i.v. and 1 μg IL-21 (PeproTech) or PBS i.p. Where indicated recipients were also given 100 μg anti-CD86 (Bio X Cell) or PBS i.p. immediately after T cell transfer. Mice were culled at day 7 for analysis of inguinal lymph node and splenic cells.
+ Open protocol
+ Expand
8

Expansion and Transduction of CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD8+CD161+ cells, CD8+CD161 cells, and bulk PBMC isolated from normal donor apheresis products were stimulated with plate bound anti-CD3/CD28 (eBioscience) and recombinant Clec2d (R&D Systems) and expanded in RPMI-1640, 10% fetal bovine serum, and 2 mmol/L GlutaMAX (Invitrogen) in a cytokine cocktail comprised of 10 ng/ml IL-7, 5 ng/ml IL-15, and 30 ng/ml IL-21 (all from Peprotech), given that IL-21 was important for maintenance of CD161 expression and phenotype. In some experiments, a second bulk PBMC control was expanded using the standard expansion protocol of only 10 ng/ml IL-7 and 5 ng/ml IL-15 to demonstrate that the presence of IL-21 during expansion made no functional impact at all upon the function of CAR-transduced bulk PBMC. After 48 hours, T cell blasts were harvested and added to retronectin (Takara Bio USA) coated plates onto which retroviral supernatants had previously been affixed by centrifugation at 2,000 × G for 60 minutes. After an additional 48 hours, transduced blasts were moved to tissues culture plates and expanded an additional 10 to 15 days in the IL-7/15/21 cocktail.
+ Open protocol
+ Expand
9

Cytokine-induced CD4+ T cell activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naïve CD4+ T cells (1 ×105 cell/well) from HC subjects (n = 6) were stimulated with dynabeads® human T-activator CD3/CD28 (Invitrogen, USA) in flat-bottom 96-well plates, and cultured in the presence of IL-12 (PeproTech, USA) (10 ng/ml), IL-21 (PeproTech, USA) (20 ng/ml), IL-12 + IL-21, or IL-17 (PeproTech, USA) (10 ng/ml) for 72 hours, respectively.
+ Open protocol
+ Expand
10

B cell differentiation with CD4+ T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human B cells were stained with 0.25 μM CFSE (Invitrogen) and plated out into a 96-well V-bottom plate (5x104 cells/well) in triplicate. Cells were stimulated for 5 days with 5 μg/mL anti-IgM (Jackson ImmunoResearch), 100 ng/mL anti-CD40 (R&D) and 10 ng/mL IL-21 (PeproTech) final concentration.
For the B cell co-culture with CD4+CD45RO+CXCR5+ T cells, CD4+ T cells were first enriched by positive selection using CD4 microbeads (Miltenyi Biotech), then stained with CD45RO (BD) and CXCR5 (Biolegend) antibodies in PBS-0.5% BSA-2 mM EDTA. CD4+CD45RO+CXCR5+ were FACS sorted on an ARIA-III (BD Bioscience).
CFSE stained B cells and CD4+CD45RO+CXCR5+ T cells were plated out into a 96-well V-bottom plate at a 1:1 ratio and cells were stimulated with SEB 10 ng/mL (SIGMA-Aldrich), IL-21 10 ng/mL and BAFF 10 ng/mL (PeproTech) final concentration. Cells were incubated for 5 days.
Supernatants were collected and antibody production was analysed using a multiplex isotyping Panel 1 kit (Meso Scale Discovery).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!